Rural healthcare is having a breakout moment in startup funding in India: healthtech startup Curebay has raised around ₹100 crore in a funding round led by IvyCap Ventures, with participation from existing investors including Elevar Equity and Bertelsmann India Investments.
Of the total capital, about ₹30 crore came in as debt from Trifecta Capital, Alteria Capital and VentureSoul Partners, with the rest as equity, The Economic Times reported on 22 October 2026.
Curebay builds a network of tech-enabled clinics serving rural and semi-urban India, pairing physical centres with AI-assisted screening and diagnostics. Co-founder and CEO Priyadarshi Mohapatra told ET the fresh capital will be used to expand the company's footprint, strengthen its technology and artificial intelligence capabilities, and enter new markets, including Andhra Pradesh.
The raise is one of the largest rural-healthtech rounds of the year and lands as investors look beyond metro markets for growth. With existing backers such as Elevar Equity and Bertelsmann doubling down, the round signals confidence that a hybrid physical-plus-AI model can make quality primary care viable in small towns.
The company will now race to open new clinics, deepen its AI screening stack, and build density in its new Andhra Pradesh market — a playbook that, if it works, could become a template for rural healthcare delivery across India.
Why it matters for founders
Curebay's ₹100 crore raise — with a meaningful ₹30 crore debt tranche — shows how later-stage healthtech rounds are increasingly structured with venture debt alongside equity. If your unit economics can carry it, debt lets you raise less dilutive capital while scaling physical infrastructure.